We looked inside some of the tweets by @JosephPetrosino and here's what we found interesting.
Inside 100 Tweets
#askreuters why is the vaccine being offered to public first rather then doctors and healthcare workers? surely we should be top priority as we have to work regardless of a virus
Admittedly, I am not up to speed on how the UK and other countries have handled their vaccine rollouts. But, I agree--the most vulnerable and most exposed should be prioritized. That has been the basis of the US strategy to this point in time. #askreuters https://t.co/PFxsXS1SsY
Whoever in DC is in charge of this National-Guard-sleeping-in-a-Senate-parking-lot mess, please get in touch with me; folks with connections to empty hotel rooms are also contacting me
Given how much taxpayer money has gone there already, can we put them up at Trump’s hotel down the street? https://t.co/tNZipojUkW
Elected officials who oversee the Montgomery County Hospital District are spreading misinformation about COVID-19 and contradicting the advice of their own health experts: https://t.co/ug2TQehOIX #hounews #coronavirus
These types of "conflicts of conscience" can and should be addressed by institutional regulatory committees, though often are not. Jeopardizing public health in this manner is what is at stake. This is not a time for mixed messages. #Covid19vaccine @PeterHotez @megzmagpie https://t.co/zS6TwURbz9
#AskReuters will the vaccine side effects affect breathing in those with asthma...or cause hives reaction in those with allergies that have reacted with a flu jab before?..asking as my son fits both categories and i want to be prepared
Data are being collected on the vaccine responses in children, hopefully those with asthma and similar allergic concerns will be included. Adults with known severe allergic reactions are advised to proceed with caution/under clinical supervision when being vaccinated.#AskReuters https://t.co/joK4wbSQ8O
Safety and efficacy tests are underway for children under 18. If successful, the CDC projects that vaccines will be available for that age group in the second half of 2021.#AskReuters https://t.co/zIJd14kss4
Is it possible to have a dose of one vaccine then a booster shot of another, or do you have to have the same vaccine twice? If you had a choice which vaccine would you choose? #AskReuters
In theory, vaccines involving the same target on the virus, e.g. the spike protein, could be given in a cross 1st/2nd dose approach. However, we have no safety data on that strategy, so it's not advised at this time. May change in the future--perhaps for a 3rd boost.#AskReuters https://t.co/dCgwcK14HE
People sometimes ask me why the vaccine rollout hasn’t been as effective as it needs to be. There’s a list of reasons, but this article captures a significant part of the problem. https://t.co/I17UOJCG0D
.@copperleaves3 People with hyper-active immune responses/severe allergies, are one category where the CDC/others have issued words of caution. If you have access to a clinician, it would be advisable to speak to them. If not, I would wait for more data before being vaccinated https://t.co/xNfdqVN9Fq
.@dorianjharris I haven't seen data suggesting one way or the other but, intuitively from what we know about the COVID related disease course and from hospitalizations, I would say that it it does not cause less severe outcomes at this time. https://t.co/oAeQcmppNJ
.@dorianjharris to date, the data suggest that #b1117 is more easily transmitted but doesn't not cause more severe disease. Masks, distancing, handwashing etc all still are good measures to reduce the risk of infection by this variant. #AskReuters https://t.co/nyGccYNTTU
#AskReuters Q, The vaccine does not stop you catching or spreading covid-19. True or false?
.@DrivesMac True for now. More data are needed to show whether or not vaccinated people can still carry the virus asymptomatically. For that reason, people who have been vaccinated should still wear masks, etc. for now. #AskReuters https://t.co/kPLB38bVKT
.@KevGoodchild People have very different responses to COVID. Some have minimal signs of long term protection following infection. We need to learn what a truly protective immune response looks like. Until then, we cannot assume everyone who had #COVID is protected. #AskReuters https://t.co/n6ZwWuVLTR
.@indylana Yes, it will likely extend the immunity you may have after recovering from COVID. It may also fortify/strengthen your immune response to future exposures as well.#AskReuters https://t.co/OufzuNnMxo
@JosephPetrosino Agree. Chronic underfunding for decades has been a huge issue. As we work on funding now (hopefully. And recognizing it'll still not be enough) what do you think we can do in the meantime to address patients' need for info?
That's the question being wrestled with daily. Direct access is a priority. The science needs to be communicated effectively. During the pandemic, experts appear routinely on various media outlets-this is needed at a community level, at places where there is equal access to info. https://t.co/ea957W17vq
@Baba_Lilith @JosephPetrosino So the question becomes how do we get high quality info to patients (not just drs) so they can be engaged in their care? How do we connect pts like you with experts who may have more info recognizing you're doing the heavy lifting to care for yourself in an inadequate system?
Cannot underscore this point enough. Community awareness and communication is something we discuss constantly (even before COVID). Public health depts are underfunded and don't have the resources to provide the best and latest for many diseases. It requires a systemic overhaul. https://t.co/VwEDM1LrAg
Unfortunately, I've heard many stories like this... rheumatoid diseases can be difficult to diagnose. While more safety data are needed, based on how they work, and unless you have a known allergy to one of the vaccine components, you should be fine with either mRNA vaccine. https://t.co/KpS1sGsFfi